Understand the source comparison
DSIP Stacking Comparison: Compatible vs High-Risk Pairings
Before stacking any peptides with DSIP, assess receptor pathway overlap, timing requirements, and known interaction data. This table summarises compatibility across common research peptide classes based on mechanism, documented interaction potential, and pract
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before stacking any peptides with DSIP, assess receptor pathway overlap, timing requirements, and known interaction data. This table summarises compatibility across common research peptide classes based on mechanism, documented interaction potential, and practical administration logistics.
- GH Secretagogues (CJC-1295, Ipamorelin, GHRP-2)
- Ghrelin receptor agonism, GHRH pathway activation
- High. No receptor overlap
- GH stack 4–6 hours pre-DSIP
- Low. Pathways independent
- Synergistic for sleep quality + GH pulsatility when timed correctly
- Nootropics (Dihexa, P21, Cerebrolysin)
- HGF modulation, BDNF upregulation, NGF mimicry
- High. Complementary CNS pathways
- Nootropic morning, DSIP evening
- Low. Mechanisms non-overlapping
- Stack enhances sleep-dependent memory consolidation
- Immune Modulators (Thymalin, KPV)
- Thymic peptide signalling, NF-κB inhibition
- High. Separate physiological systems
- Thymalin morning, DSIP evening
- Minimal. Indirect HPA-immune synergy possible
- Compatible with no documented adverse interactions
- Metabolic Compounds (Tesofensine, Lipo C)
- Monoamine reuptake inhibition, lipotropic cofactors
- Moderate. CNS activity overlap requires monitoring
- Metabolic morning only, DSIP evening
- Moderate. Potential additive CNS effects
- Safe if dosed conservatively; avoid evening metabolic dosing
- Other GABA Modulators (Selank, Semax analogs)
- GABA-A/B receptor modulation, anxiolytic pathways
- Low. Direct receptor competition
- Not recommended for stacking
- High. Competitive binding reduces efficacy
- Avoid concurrent use; choose one or cycle separately
- Delta-Opioid Agonists (research analogs)
- Delta-opioid receptor activation
- Very Low. Same primary target
- Contraindicated for stacking
- Very High. Receptor saturation, unpredictable dose-response
- Do not stack; receptor occupancy conflict